Enfusion Inc (ENFN) Insider Trading
- $21,447,098.00
- $57,851,268.10
- Dec. 2, 2024
- Dan Groman
Trader Name | Date | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|---|
Dec. 2, 2024 | COO | 21,801 | $10.03 | Sell | $218,664.03 | |
Oct. 22, 2024 | General Counsel | 674 | $8.95 | Sell | $6,032.30 | |
June 20, 2024 | Insider | 18,241 | $8.11 | Sell | $147,934.51 | |
June 14, 2024 | Director | 4,629 | $8.40 | Sell | $38,883.60 | |
Feb. 29, 2024 | CAO | 27 | $8.73 | Sell | $235.71 | |
Feb. 29, 2024 | General Counsel | 108 | $8.73 | Sell | $942.84 | |
Jan. 10, 2024 | Director | 1,770 | $8.65 | Sell | $15,310.50 | |
Jan. 8, 2024 | General Counsel | 472 | $9.23 | Sell | $4,356.56 | |
Jan. 8, 2024 | CFO | 1,998 | $9.23 | Sell | $18,441.54 | |
Jan. 8, 2024 | Insider | 391 | $9.23 | Sell | $3,608.93 | |
Jan. 8, 2024 | CEO | 1,295 | $9.23 | Sell | $11,952.85 | |
Dec. 14, 2023 | CEO | 100,000 | $10.01 | Sell | $1,001,000.00 | |
Dec. 1, 2023 | CEO | 150,000 | $10.09 | Sell | $1,513,500.00 | |
Nov. 27, 2023 | Major Shareholder | 1,000,000 | $9.86 | Sell | $9,860,000.00 | |
Nov. 14, 2023 | CTO | 5,000 | $9.97 | Sell | $49,850.00 | |
Oct. 17, 2023 | CTO | 5,000 | $9.09 | Sell | $45,450.00 | |
Sept. 19, 2023 | CTO | 5,000 | $9.07 | Sell | $45,350.00 | |
Aug. 14, 2023 | CTO | 1,760 | $7.89 | Sell | $13,886.40 | |
Aug. 14, 2023 | Insider | 41 | $7.89 | Sell | $323.49 | |
Aug. 11, 2023 | Insider | 44 | $8.10 | Sell | $356.40 | |
Aug. 11, 2023 | CTO | 1,850 | $8.10 | Sell | $14,985.00 | |
Aug. 9, 2023 | Insider | 55 | $8.32 | Sell | $457.60 | |
Aug. 9, 2023 | CTO | 2,317 | $8.32 | Sell | $19,277.44 | |
July 17, 2023 | CTO | 3,877 | $11.31 | Sell | $43,848.87 | |
July 11, 2023 | Major Shareholder | 1,000,000 | $10.70 | Sell | $10,700,000.00 | |
June 20, 2023 | CTO | 3,877 | $8.86 | Sell | $34,350.22 | |
May 10, 2023 | CTO | 15,048 | $8.34 | Sell | $125,500.32 | |
April 17, 2023 | CTO | 3,877 | $9.66 | Sell | $37,451.82 | |
March 17, 2023 | CTO | 3,877 | $10.94 | Sell | $42,414.38 | |
March 8, 2023 | Major Shareholder | 1,000,000 | $11.35 | Sell | $11,350,000.00 | |
Jan. 17, 2023 | CTO | 3,877 | $10.93 | Sell | $42,375.61 | |
Nov. 11, 2022 | Major Shareholder | 1,000,000 | $12.15 | Sell | $12,150,000.00 | |
Oct. 25, 2021 | Major Shareholder | 647,862 | $15.89 | Sell | $10,294,527.18 | |
Oct. 25, 2021 | Director | 1,261,594 | $17.00 | Buy | $21,447,098.00 |
Insiders are both buying and selling Enfusion Inc stock.
The insider traders at Enfusion Inc are: Dan Groman, Bronwen Bastone, Matthew Campobasso, Oleg Movchan, Tarek Hammoud, Deirdre Somers, Stephen Malherbe, Valeria Gutowski, Hillhouse Investment Managemen, Neal Pawar, Roy Luo, and Bradley Herring
The most active insider trader at Enfusion Inc is Dan Groman with 12 trades.
Tarek Hammoud has sold the most Enfusion Inc stock with a total value of $33,550,000.00.
Roy Luo has bought the most Enfusion Inc stock with a total value of $42,894,196.00.
The most recent insider trade for Enfusion Inc was on Dec. 2, 2024.
The single biggest insider buy for Enfusion Inc was from Roy Luo with a total value of $21,447,098.00 on Oct. 25, 2021.
The single biggest insider sell for Enfusion Inc was from Tarek Hammoud with a total value of $12,150,000.00 on Nov. 11, 2022.